Abstract
Ms. Eberle examines the Bayh-Doyle Act of 1980, which allows small entities to retain patent title to inventions arising from federally funded research. The Act includes a march-in rights provision, which permits a petitioning third party to force the small entity to grant the petitioner a license where the original licensee fails to commercialize the technology. Ms. Eberle discusses the substance of the Act, focusing on its march-in rights provision. Next, Eberle chronicles a march-in rights attempt by the biotechnology company CellPro to obtain a license to Johns Hopkins University patents and the subsequent court battle. After offering an analysis of the issues associated with CellPro's request, the author concludes that march-in rights can serve health needs without upsetting the technology transfer process if exercised under the strict circumstances enumerated in the Act is reached.
Repository Citation
Mary Eberle,
March-In Rights Under the Bayh-Dole Act: Public Access to Federally Funded Research ,
3 Marq. Intellectual Property L. Rev. 155
(1999).
Available at: https://scholarship.law.marquette.edu/iplr/vol3/iss1/5